The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Related News Articles

Headline
The AHA today expressed support for the Resident Physician Shortage Reduction Act (H.R. 4731 /S. 2439) to House and Senate sponsors of the bills. The…
Headline
Bipartisan, bicameral legislation supported by the AHA to address the ongoing nurse and physician shortage was reintroduced in Congress yesterday. The…
Headline
Newsweek’s Access Health newsletter today features a conversation with AHA Chair Tina Freese Decker, president and CEO of Corewell Health in Michigan, where…
Headline
A recent blog by Elisa Arespacochaga, AHA’s group vice president of clinical affairs and workforce, highlights how some hospitals and health systems are…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…